Global Clinical Trial Imaging Market Report and Forecast 2023-2031

Global Clinical Trial Imaging Market Report and Forecast 2023-2031


Global Clinical Trial Imaging Market Outlook
The global clinical trial imaging market attained a value of USD 1.3 billion in 2022, driven by increasing number of clinical trials and advancements in imaging technologies. The market is expected to grow at a CAGR of 8.05% during the forecast period of 2023-2031 to attain a value of USD 2.5 billion by 2031.

Clinical Trial Imaging: Introduction

Clinical trial imaging refers to the use of various imaging modalities, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and ultrasound, in clinical trials to assess and monitor the effects of investigational drugs or therapies on patients. It involves the acquisition, analysis, and interpretation of images to evaluate treatment response, disease progression, and safety outcomes. Clinical trial imaging offers several uses and benefits in the context of drug development and clinical research.

The uses of clinical trial imaging include:
  • Treatment Response Assessment: Imaging techniques are employed to evaluate the response of patients to investigational drugs or therapies. They help assess the reduction in tumor size, changes in tumour characteristics, or improvements in disease-related biomarkers, providing objective measures of treatment efficacy.
  • Disease Progression Monitoring: Imaging plays a crucial role in tracking disease progression and understanding the natural course of the disease. By capturing images at multiple time points during a clinical trial, researchers can assess disease dynamics, identify disease-related changes, and make informed decisions regarding treatment modifications or patient management.
  • Safety Evaluation: Clinical trial imaging allows for the detection and monitoring of potential adverse effects or toxicities associated with investigational drugs or therapies. It helps identify any treatment-related complications, such as organ toxicity, changes in tissue structure, or abnormal physiological functions, enabling early intervention and improved patient safety.
  • Patient Selection and Stratification: Imaging can assist in patient selection and stratification for clinical trials. It helps identify patients with specific disease characteristics or biomarkers that may predict treatment response, aiding in the design of more targeted and personalized clinical trials.
  • Pharmacokinetic Studies: Imaging techniques, such as PET or MRI, can be utilized to assess the pharmacokinetics of drugs, tracking their distribution, metabolism, and elimination in the body. This information helps optimize drug dosing, determine optimal treatment regimens, and guide drug development decisions.
The benefits of clinical trial imaging include:
  • Objective and Quantitative Measurements: Imaging provides objective and quantitative data, enabling standardized assessments of treatment response and disease progression. This reduces subjectivity and enhances the reliability and reproducibility of study outcomes.
  • Early Detection of Treatment Response: Clinical trial imaging allows for the early detection of treatment response or lack thereof. This facilitates prompt adjustments in treatment strategies, leading to improved patient outcomes and more efficient clinical trial design.
  • Improved Trial Efficiency: The use of imaging in clinical trials can enhance trial efficiency by providing timely and accurate assessments of treatment effects. This can result in shorter trial durations, reduced sample sizes, and improved cost-effectiveness.
  • Non-Invasive Monitoring: Imaging techniques offer non-invasive methods of monitoring disease progression and treatment response, reducing the need for invasive procedures or repeated biopsies. This enhances patient comfort and compliance during clinical trials.
  • Enhanced Decision-making: Clinical trial imaging provides valuable information for decision-making, enabling researchers and clinicians to make more informed choices regarding treatment efficacy, patient selection, and drug development strategies.
It is important to note that the appropriate selection of imaging modalities, standardized imaging protocols, and rigorous image analysis methodologies are crucial for ensuring the accuracy and reliability of imaging data in clinical trials. Adherence to regulatory guidelines and ethical considerations regarding patient safety and privacy is essential throughout the imaging process.
Clinical Trial Imaging Market Segmentations

The market can be categorised into products and services, application, modality, end user, and region.

Market Breakup by Products and Services
  • Services
  • Software
Market Breakup by Application
  • Trial Design Consulting Services
  • Read Analysis Services
  • Operational Imaging Services
  • Imaging Software
Market Breakup by Modality
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
  • Other Modalities
Market Breakup by End User
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Manufacturers
  • Academic and Government Research Institutes
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Clinical Trial Imaging Market Overview
The clinical trial imaging market has experienced substantial growth and is expected to continue expanding in the coming years. Several factors contribute to the positive market scenario.

One of the primary drivers of market growth is the increasing number of clinical trials conducted worldwide. The pharmaceutical and biotechnology industries are investing heavily in drug development, and imaging plays a critical role in assessing treatment response and monitoring the safety and efficacy of investigational drugs. The rising demand for imaging services in clinical trials drives the growth of the clinical trial imaging market.

Moreover, the advancements in imaging technologies have significantly contributed to market expansion. The development of high-resolution imaging modalities, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and molecular imaging, has improved the quality and accuracy of imaging data obtained during clinical trials. These advanced imaging techniques enable researchers to visualize and quantify treatment effects, disease progression, and therapeutic response, leading to more precise and reliable study outcomes.

Furthermore, the growing emphasis on personalized medicine and targeted therapies has increased the utilization of imaging in clinical trials. Imaging techniques play a crucial role in patient selection and stratification, enabling researchers to identify individuals with specific disease characteristics or biomarkers that may predict treatment response. This facilitates the design of more targeted and efficient clinical trials, leading to improved treatment outcomes and patient care.

In conclusion, the clinical trial imaging market is expected to witness continued growth due to the increasing number of clinical trials, advancements in imaging technologies, the emphasis on personalized medicine, and the recognition of regulatory agencies. The integration of imaging in clinical trials enhances the efficiency, accuracy, and reliability of study outcomes, leading to better decision-making in drug development and improved patient care. Continued investment in research and development, technological innovations, and collaborations between imaging service providers, pharmaceutical companies, and contract research organizations (CROs) will shape the future of the clinical trial imaging market.

Key players in the global clinical trial imaging market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the clinical trial imaging market are as follows:
  • Navitas Life Sciences
  • BioTelemetry
  • ICON PLC
  • IXICO plc.
  • Image Core Lab
  • anagram 4 clinical trials
  • Quotient Sciences
  • WORLDCARE CLINICAL
  • Paraxel International Corporation
  • Median Technologies
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Imaging Market Overview
3.1 Global Clinical Trial Imaging Market Historical Value (2016-2022)
3.2 Global Clinical Trial Imaging Market Forecast Value (2023-2031)
4 Global Clinical Trial Imaging Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Clinical Trial Imaging Market Segmentation
5.1 Global Clinical Trial Imaging Market by Products and Services
5.1.1 Market Overview
5.1.2 Services
5.1.3 Software
5.2 Global Clinical Trial Imaging Market by Application
5.2.1 Market Overview
5.2.2 Trial Design Consulting Services
5.2.3 Read Analysis Services
5.2.4 Operational Imaging Services
5.2.5 Imaging Software
5.3 Global Clinical Trial Imaging Market by Modality
5.3.1 Market Overview
5.3.2 Magnetic Resonance Imaging
5.3.3 Computed Tomography
5.3.4 Ultrasound
5.3.5 Positron Emission Tomography
5.3.6 X-Ray
5.3.7 Echocardiography
5.3.8 Other Modalities
5.4 Global Clinical Trial Imaging Market by End User
5.4.1 Market Overview
5.4.2 Pharmaceutical and Biotechnology Companies
5.4.3 Medical Device Manufacturers
5.4.4 Academic and Government Research Institutes
5.5 Global Clinical Trial Imaging Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Clinical Trial Imaging Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Clinical Trial Imaging Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Clinical Trial Imaging Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Clinical Trial Imaging Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Clinical Trial Imaging Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Navitas Life Sciences
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BioTelemetry
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ICON PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 IXICO plc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Image Core Lab
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 anagram 4 clinical trials
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Quotient Sciences
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 WORLDCARE CLINICAL
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Paraxel International Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Median Technologies
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings